D
grade
Efficacy of GLP-1-based Therapies on Metabolic Dysfunction-associated Steatotic Liver Disease and Metabolic Dysfunction-associated Steatohepatitis: A Systematic Review and Meta-analysis.
Efinopegdutide · The Journal of clinical endocrinology and metabolism · 2025 · Meta-analysisHigh-impact journal
GLP-1 receptor agonists may reduce liver fat and improve liver histology in patients with metabolic liver diseases, but the effects on fibrosis are not clear.
5.21% reduction in liver fat content after 24 weeks, n=2600.